Kane Biotech Stock Market Value
| KNBIF Stock | USD 0.08 0.0003 0.39% |
| Symbol | Kane |
Kane Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kane Biotech's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kane Biotech.
| 08/29/2024 |
| 11/27/2024 |
If you would invest 0.00 in Kane Biotech on August 29, 2024 and sell it all today you would earn a total of 0.00 from holding Kane Biotech or generate 0.0% return on investment in Kane Biotech over 90 days. Kane Biotech is related to or competes with Pharming Group. Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies ... More
Kane Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kane Biotech's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kane Biotech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 29.8 | |||
| Value At Risk | (2.81) |
Kane Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kane Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kane Biotech's standard deviation. In reality, there are many statistical measures that can use Kane Biotech historical prices to predict the future Kane Biotech's volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (0.51) | |||
| Total Risk Alpha | (1.00) | |||
| Treynor Ratio | (5.00) |
Kane Biotech Backtested Returns
Kane Biotech has Sharpe Ratio of -0.16, which conveys that the firm had a -0.16% return per unit of risk over the last 3 months. Kane Biotech exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Kane Biotech's Standard Deviation of 3.19, mean deviation of 1.22, and Risk Adjusted Performance of (0.11) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.0999, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Kane Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Kane Biotech is expected to be smaller as well. At this point, Kane Biotech has a negative expected return of -0.5%. Please make sure to verify Kane Biotech's treynor ratio and the relationship between the daily balance of power and relative strength index , to decide if Kane Biotech performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.06 |
Very weak reverse predictability
Kane Biotech has very weak reverse predictability. Overlapping area represents the amount of predictability between Kane Biotech time series from 29th of August 2024 to 13th of October 2024 and 13th of October 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kane Biotech price movement. The serial correlation of -0.06 indicates that barely 6.0% of current Kane Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.06 | |
| Spearman Rank Test | -0.12 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Kane Biotech lagged returns against current returns
Autocorrelation, which is Kane Biotech otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Kane Biotech's otc stock expected returns. We can calculate the autocorrelation of Kane Biotech returns to help us make a trade decision. For example, suppose you find that Kane Biotech has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Kane Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Kane Biotech otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Kane Biotech otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Kane Biotech otc stock over time.
Current vs Lagged Prices |
| Timeline |
Kane Biotech Lagged Returns
When evaluating Kane Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Kane Biotech otc stock have on its future price. Kane Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Kane Biotech autocorrelation shows the relationship between Kane Biotech otc stock current value and its past values and can show if there is a momentum factor associated with investing in Kane Biotech.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Kane OTC Stock
Kane Biotech financial ratios help investors to determine whether Kane OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kane with respect to the benefits of owning Kane Biotech security.